Company type | Public |
---|---|
| |
Industry | Healthcare |
Founded |
|
Headquarters | Heller International Building, Chicago, Illinois , United States |
Area served | Worldwide |
Key people |
|
Revenue | US$19.6 billion (2023) |
US$2.4 billion (2023) | |
US$1.6 billion (2023) | |
Total assets | US$32.5 billion (2023) |
Total equity | US$7.2 billion (2023) |
Owner | GE Aerospace (6.7%) |
Number of employees | c. 51,000 (2023) |
Website | gehealthcare |
Footnotes / references [1][2][3][4] |
GE HealthCare Technologies, Inc.[5] is an American multinational medical technology company headquartered in Chicago, Illinois.[6] It was spun-off from General Electric on January 4, 2023, with GE retaining 6.7%. As of 2017, it is a manufacturer and distributor of diagnostic imaging agents and radiopharmaceuticals for imaging modalities used in medical imaging procedures. It offers dyes used in magnetic-resonance-imaging procedures; manufactures medical diagnostic equipment, including CT image machines; MRI, X-ray; ultrasound; cath labs; mammogram; Nuclear Medicine Cameras; and develops health technology for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery, and biopharmaceutical manufacturing. It was incorporated in 1994[7] and operates in more than 100 countries.
On November 9, 2021, General Electric announced it would split into three investment-grade public companies, with GE HealthCare being one of the three planned divestitures. GE HealthCare completed its spin-off on January 4, 2023,[8] with the company being listed on the Nasdaq Stock Market.[9]